Annual rate of transvenous defibrillation lead defects in implantable cardioverter-defibrillators over a period of >10 years. - Wikidata - wikimedia - TriplyDB

Annual rate of transvenous defibrillation lead defects in implantable cardioverter-defibrillators over a period of >10 years.

Annual rate of transvenous defibrillation lead defects in implantable cardioverter-defibrillators over a period of >10 years.

http://www.wikidata.org/entity/Q34624387

about

Remote monitoring of patients with implanted cardiac devices.Subcutaneous implantable defibrillator: State-of-the art 2013.The Wearable Cardioverter/Defibrillator - Toy Or Tool?A Questionable Indication For ICD Extraction After Successful VT Ablation Use of remote monitoring in the management of system-related complications in implantable defibrillator patients Remote monitoring in implantable defibrillator therapy.Real-world data on the lifespan of implantable cardioverter-defibrillators depending on manufacturers and the amount of ventricular pacing.Managing patients with advisory defibrillator leads: what can we learn from published data?Long-term follow-up of children and adolescents diagnosed with hypertrophic cardiomyopathy: risk factors for adverse arrhythmic events."Add-on pacing lead": an effective and safe alternative to lead replacement in ICD pacing failure.Generator and lead-related complications of implantable cardioverter defibrillators.Worldwide experience with a totally subcutaneous implantable defibrillator: early results from the EFFORTLESS S-ICD Registry [Cardiac resynchronisation therapy : new data and technical developments].Contributions of remote monitoring to the follow-up of implantable cardioverter-defibrillator leads under advisory Clinical experience with a novel subcutaneous implantable defibrillator system in a single center.Routine issuance of clinical magnets to patients receiving implantable defibrillators: retention of information and appropriateness of use.Predictors and clinical impact of inappropriate implantable cardioverter-defibrillator shocks in Korean patients.A Case of Arterial and Venous Tear during Single Lead Extraction Internet-based device-assisted remote monitoring of cardiovascular implantable electronic devices: an evidence-based analysis.Leadless Cardiac Devices-Pacemakers and Implantable Cardioverter-Defibrillators.Transvenous implantable cardioverter-defibrillator lead reliability: implications for postmarket surveillance Initial experience of subcutaneous implantable cardioverter defibrillators in Singapore: a case series and review of the literature Reduced appropriate implantable cardioverter-defibrillator therapy after cardiac resynchronization therapy-induced left ventricular function recovery: a meta-analysis and systematic review.Hybrid Minimally Invasive Approach for Transvenous Lead Extraction: A Feasible Technique in High-Risk Patients.Evaluation of tricuspid valve regurgitation following laser lead extraction†.Extraction of a CardioFix neurostimulator with concomitant laser-assisted lead and intracardiac cardiac defibrillator extraction due to Staphylococcus aureus pocket infection.Use and Abuse of Internal Cardioverter Defibrillators for Primary Prevention.The Entirely Subcutaneous Defibrillator - A New Generation and Future Expectations.Failure of a novel silicone-polyurethane copolymer (Optim™) to prevent implantable cardioverter-defibrillator lead insulation abrasions.Long-term performance of the St Jude Riata 1580-1582 ICD lead family.Transvenous Implantable Cardioverter-Defibrillator (ICD) Lead Performance: A Meta-Analysis of Observational Studies.Primary prevention with the ICD in clinical practice: not as straightforward as the guidelines suggest?National Trends in the Use of Cardiac Resynchronization Therapy With or Without Implantable Cardioverter-Defibrillator.Externalized conductors and insulation failure in Biotronik defibrillator leads: History repeating or a false alarm?From lead management to implanted patient management: indications to lead extraction in pacemaker and cardioverter-defibrillator systems.Premature failure of a Riata defibrillator lead without impedance change or inappropriate sensing: a case report and review of the literature.A plea for the wider use of CRT-P in candidates for cardiac resynchronisation therapy.Dual- versus single-coil implantable defibrillator leads: review of the literature.Subcutaneous chronic implantable defibrillation systems in humans.Feasibility and safety of same-day discharge after implantable cardioverter defibrillator placement for primary prevention.

P2860

Q27686906-6EABFFFC-39ED-4D89-97E5-1798ABBFBD00 Q27691421-3344E658-43D0-4208-8480-8CBD959EE972 Q28077810-F1B3498E-1817-4EEB-AFEE-BCC5526688FA Q28082167-4527B8E6-2046-4C99-B89A-F59B230F1DCE Q30470330-DABCABA2-38F0-4094-A0AE-ACEF44602B33 Q30496677-5C7FC07B-F394-4102-AFFA-6E6961001A5D Q30558560-53444EE1-FAB2-4C42-91DE-F08A6B3D9642 Q30934904-28B536D8-F6B0-46CB-B5D3-7C1A854CFE3D Q33159927-D32B82A8-7127-4D85-8D10-B1895331A3E9 Q33161697-A929D55E-6241-4FD9-AC15-8CDF8231B0C0 Q33758753-A74B3B30-F06E-4C86-8621-ED55AB684DCA Q33827116-5F584C10-6EC8-4E5E-8D9F-B0AECCC717C8 Q34018067-2EEE550E-7C4A-4201-95EA-1202A65D2DA3 Q34123768-94CEBC14-AD87-46FA-8F1D-53B88C4D63F7 Q35196552-7D635E0A-C780-4ED6-825F-C173DF86FF07 Q35640144-6F5CACF2-6DD7-4A15-9F6E-C3449A287167 Q36014445-E81325BC-61C4-4CDA-9D6E-54EC27C2573A Q36022017-777C3659-9E0A-434D-911A-07E7DA53C4AF Q36040218-A71B6153-7440-4862-9BA8-1DA89CEFB6C8 Q36049115-F92A6D0B-C7A4-42CA-B5EB-F307ED89A32D Q36141948-600EF16F-FAF0-484E-BE4A-C750A650741A Q36186091-2F657BC3-A703-49B9-82A3-4625DF0D70DA Q36236154-99682CC8-6513-4B21-80AF-204E72DCE89C Q36243647-AF82754E-0581-4D8D-AF13-3E6EAAC62920 Q36282016-BEB9B5B9-D6F2-4859-8C44-B51A942F4B17 Q36368433-644ECA20-8781-4ADE-8DEA-61397EF33B5A Q36458785-BCFEB116-6A70-476B-B88B-9E85FB83B061 Q36458920-3FE8337C-628B-412A-B34A-C7F15537F662 Q36545971-727E6532-0CA7-4FD2-902A-66B661854D0C Q36627317-EE84665C-0CA5-4506-99DD-F3E2B4A0ACF9 Q36836212-817DFEA6-D234-4826-AB06-0EF5D7369F1A Q37424865-C65BE667-3CFF-4982-994B-2EC170735C7E Q37602252-6054EDC3-67BC-4212-AFB7-C61A2BF9D4DB Q37648443-431A49F6-19BC-42C7-8554-460863EEB0F6 Q37850450-E384B163-83B7-4A76-B469-4AC964BDEE15 Q37850832-7232D665-CBF3-4464-B71A-EC4A06C940DA Q37904878-820A8B44-AF7A-46C3-92F5-CDACE8A42C22 Q37974552-D706B6B9-E2C5-402D-B80B-571B898DD3DF Q37994562-A823D3C9-2DAD-43D9-8AFA-BF5AEF8B0692 Q38101629-75E933A4-642C-4C8F-96CB-CC98C0D62D34

P2860

Annual rate of transvenous defibrillation lead defects in implantable cardioverter-defibrillators over a period of >10 years.

http://www.wikidata.org/entity/Q34624387

description

2007 nî lūn-bûn

@nan

2007 թուականի Ապրիլին հրատարակուած գիտական յօդուած

@hyw

2007 թվականի ապրիլին հրատարակված գիտական հոդված

@hy

2007年の論文

@ja

2007年論文

@yue

2007年論文

@zh-hant

2007年論文

@zh-hk

2007年論文

@zh-mo

2007年論文

@zh-tw

2007年论文

@wuu

name

Annual rate of transvenous def ...... rs over a period of >10 years.

@ast

Annual rate of transvenous def ...... rs over a period of >10 years.

@en

Annual rate of transvenous def ...... rs over a period of >10 years.

@nl

type

label

Annual rate of transvenous def ...... rs over a period of >10 years.

@ast

Annual rate of transvenous def ...... rs over a period of >10 years.

@en

Annual rate of transvenous def ...... rs over a period of >10 years.

@nl

prefLabel

Annual rate of transvenous def ...... rs over a period of >10 years.

@ast

Annual rate of transvenous def ...... rs over a period of >10 years.

@en

Annual rate of transvenous def ...... rs over a period of >10 years.

@nl

P1433

Q34624387-36191AF5-6000-48D0-B0CD-70AF50B4FADF

P1476

Q34624387-8299575D-37EC-4A39-9513-8A8922DE0DA0

P2093

Q34624387-020F4EC4-45FC-44B3-A6A2-76042B24A55B

Q34624387-2CBAAC83-61BA-434B-ACD2-1A74A0759762

Q34624387-467B560D-D7D8-47FF-8382-E5085B0CEA61

Q34624387-4D7DEDA9-8967-4AE0-A059-F1E2AC1A5D6F

Q34624387-81E26398-7E4B-4FB5-8FF8-D453BAD41510

Q34624387-AA8C7F2D-44BF-4717-BB2F-1470AB520C96

Q34624387-AF46555E-FEA7-4CDE-964A-EB2F6E036B5F

Q34624387-EF6BD348-45E0-40C0-AD11-F525878E0494

Q34624387-F7E232F9-FC75-446F-B7DC-EEFEB66EA27C

P304

Q34624387-4D71E3A8-EB25-410A-8329-CEF6D4808B54

P31

Q34624387-4F3D2617-0676-42F1-8A88-A3D1991759A5

P356

Q34624387-9E1BE932-5F24-4EA7-B9EC-6788379F1D14

P407

Q34624387-4DD17C30-4ACD-4AAB-B153-C25FAC987A58

P433

Q34624387-6335FF45-8735-4FC3-A94C-39381E4B53EC

P478

Q34624387-C2AA65E3-AA1E-4B3C-A5C2-D029CA49961C

P577

Q34624387-FD4D1AA6-DF6C-499D-A789-0BDE53F96DDE

P698

Q34624387-82795202-F974-4175-AE85-49D0EFD7F494

P921

Q34624387-79C87075-7306-4EB3-9E01-7BAC88AC8D92

P356

CIRCULATIONAHA.106.663807

P1433

P1476

Annual rate of transvenous def ...... rs over a period of >10 years.

@en

P2093

Jochen Senges

http://www.w3.org/2001/XMLSchema#string

Karlheinz Seidl

http://www.w3.org/2001/XMLSchema#string

Klaus Doenges

http://www.w3.org/2001/XMLSchema#string

Margit Vater

http://www.w3.org/2001/XMLSchema#string

Steffen Schneider

http://www.w3.org/2001/XMLSchema#string

Thomas Kleemann

http://www.w3.org/2001/XMLSchema#string

Torsten Becker

http://www.w3.org/2001/XMLSchema#string

Udo Weisse

http://www.w3.org/2001/XMLSchema#string

Werner Saggau

http://www.w3.org/2001/XMLSchema#string

P304

2474-2480

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1161/CIRCULATIONAHA.106.663807

http://www.w3.org/2001/XMLSchema#string

P407

P433

19

http://www.w3.org/2001/XMLSchema#string

P478

115

http://www.w3.org/2001/XMLSchema#string

P577

2007-04-30T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

17470696

http://www.w3.org/2001/XMLSchema#string

P921